Your session is about to expire
← Back to Search
Behavioral Intervention
Single-Session Intervention for Domestic Violence
N/A
Recruiting
Led By Tami Sullivan, PhD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Self-identify as a woman (cis- or trans-gender woman)
Currently in a relationship of at least 3 months duration in which they have experienced physical IPV by a male partner
Must not have
Not comfortable conversing, reading, or writing in English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (pre intervention) and up to one month (post intervention)
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to create a short self-guided session to help increase hope among women who are experiencing intimate partner violence. The study will have two stages: developing the intervention and testing it. This registration
Who is the study for?
This trial is for women who are experiencing intimate partner violence (IPV). It aims to help them develop or increase feelings of hope. Participants should be interested in a self-guided, one-time session designed to improve their emotional wellbeing.
What is being tested?
The study is testing a brief, self-guided single-session intervention (SSI) focused on fostering hope. The pilot stage will assess how feasible and safe the SSI is, and if it's liked by participants. It also looks at its effect on hope, self-worth, empowerment, and overall emotional health.
What are the potential side effects?
Since this intervention involves psychological support without medications or medical procedures, there may not be physical side effects. Emotional discomfort could arise when discussing sensitive topics like IPV.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I identify as a woman.
Select...
I have been in a relationship for 3+ months and experienced physical abuse from a male partner.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am not comfortable with English for conversation, reading, or writing.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to one month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to one month
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Acceptability/likability assessed using the Program Feeback Scale
Change in Hope assessed using Beck Hopelessness Scale (single item)
Change in Hope assessed using Herth Hope Index
+5 moreSecondary study objectives
Change in Emotional wellbeing measured by the Patient Health Questionnaire-2 (PHQ-2)
Change in Emotional wellbeing measured by the State Joy Scale
Change in Empowerment assessed using The Personal Progress Scale-Revised (PPS-R)
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Single-Session Intervention to Promote HopeExperimental Treatment1 Intervention
A 30-45 minute self-guided intervention delivered in a web browser.
Find a Location
Who is running the clinical trial?
Yale UniversityLead Sponsor
1,930 Previous Clinical Trials
3,033,393 Total Patients Enrolled
Office on Violence Against Women (OVW)UNKNOWN
Center for Family JusticeUNKNOWN
Connecticut Coalition Against Domestic ViolenceUNKNOWN
Tami Sullivan, PhDPrincipal InvestigatorDepartment of Psychiatry, Yale School of Medicine
1 Previous Clinical Trials
666 Total Patients Enrolled